ProMIS Neurosciences Announces Expanded License Agreement with The University of British …

ProMIS Neurosciences Announces Expanded License Agreement with The University of British …

TORONTO, Oct. 8, 2015 /CNW/ – ProMIS Neurosciences, Inc. (TSX: PMN), announced today that it has entered into an exclusive license agreement to develop and commercialize intellectual property rights belonging to The University of British Columbia (UBC). This agreement significantly expands upon the original agreement from February 2009, and affords exclusive worldwide rights to intellectual property based on use of the ProMISTM technology, modifications and enhancements to ProMISTM, as well as eventual new technologies under development. Terms and conditions of the agreement were not disclosed.There has been a developing consensus in the neuroscience community that propagating, misfolded proteins (for example, prions) are fundamental drivers of multiple neurodegenerative diseases, including Alzheimer’s disease (AD), ALS (amyotrophic lateral sclerosis) and Parkinson’s disease. At the recent ANA annual meeting held in Chicago, speakers at the…